|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.1745 SEK | -2.79% |
|
+7.72% | -38.56% |
| 08-28 | Xintela AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-01 | Flerie portfolio company Xintela reports positive study results for stem cell product | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XINTELA AB | Other Biotechnology & Medical Research | -2.79% | +7.72% | -38.56% | -55.48% | -91.36% | 14.98M |
-
|
-
|
-
|
- Stock Market
- Stocks
- XINT Stock
- Charts Xintela AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
